Researchers at Skoltech have developed an ultra-compact electro-optic modulator based on silicon photonics and plasmonics ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
EPC’s evaluation kit for a three-phase inverter platform based on its Gen-7 EPC2366 eGaN power transistor streamlines motor ...
Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-stage biopharmaceutical company focused on cellular energy restoration therapeutic ...
Have you ever wished to drive microscopic matter along an arbitrarily tailored trajectory instead of just a circle? That's ...
Researchers led by Professor Ting Mei (Northwestern Polytechnical University) and Professors Xiaocong Yuan & Yuquan Zhang ...
Scientists have unveiled a breakthrough imaging method that can capture the hidden details of events unfolding in trillionths ...
A novel imaging method captures ultrafast events with unprecedented detail by combining laser encoding and AI reconstruction. Researchers have introduced a new imaging method that reveals far more ...
Energenesis Biomedical Co., Ltd. (TWSE: 6657), a clinical-stage biopharmaceutical company focused on cellular energy restoration therapeutics, today announced ...
A rolling NDA has been initiated for tinlarebant in STGD1, potentially positioning the first disease-modifying systemic ...
FB301 was safe and well tolerated in healthy female subjects, with all primary and secondary endpoints metClinically meaningful microbiome ...
Sweet proteins such as brazzein add an exciting new dimension to the sugar-reduction toolbox, claims Pentasweet.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results